Teva Investigational Site 22 — Duluth, Minnesota

Teva Investigational Site 22 is a clinical research site located in Duluth, Minnesota, United States.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Teva Investigational Site 22 has participated in 1 clinical trials.

Therapeutic areas: Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma.

Sponsors: Teva Branded Pharmaceutical Products R&D, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Duluth

Browse all research sites in Minnesota · View every site in Duluth

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Teva Investigational Site 22?

Teva Investigational Site 22 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Teva Investigational Site 22 conducted?

Teva Investigational Site 22 has 1 clinical trials on record. Their work covers Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma.

Is Teva Investigational Site 22 accredited by Crixeo Clinical Trials?

Teva Investigational Site 22 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Teva Investigational Site 22?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.